• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NDUFA12L线粒体复合物I组装因子:与tau蛋白病的关联

NDUFA12L mitochondrial complex-I assembly factor: Implications for taupathies.

作者信息

Salama Mohamed, Mohamed Wael M Y

机构信息

Toxicology Department, Mansoura University, Egypt.

Clinical Pharmacology Dept, Menoufia Medical School, Menoufia University, Egypt.

出版信息

Appl Transl Genom. 2015 Jun 18;5:37-9. doi: 10.1016/j.atg.2015.05.003. eCollection 2015 Jun 1.

DOI:10.1016/j.atg.2015.05.003
PMID:26937358
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4745364/
Abstract

There is a strong correlation between taupathies and the development and progression of neurodegenerative disorders. Abnormal tau becomes hyperphosphorylated and dissociated from microtubules with the aggregation of intracellular tau aggregates within the patient's brain. The current review is divided into two broad sections. In the first section we discuss the molecular biology and the clinicopathologic features of taupathies. While in the second section we discuss the relationship between mitochondrial complex-I and taupathies. Polymorphism in NDUFA12L may be a crucial factor for development of neurodegenerative taupathies. Thus NDUFA12L screening may be an early biomarker for identifying risk groups for such disorders.

摘要

tau蛋白病与神经退行性疾病的发生和发展之间存在密切关联。异常的tau蛋白发生过度磷酸化并与微管解离,同时患者脑内会形成细胞内tau蛋白聚集体。本综述分为两个主要部分。在第一部分中,我们讨论tau蛋白病的分子生物学和临床病理特征。而在第二部分中,我们讨论线粒体复合体I与tau蛋白病之间的关系。NDUFA12L基因多态性可能是神经退行性tau蛋白病发生发展的关键因素。因此,对NDUFA12L进行筛查可能是识别此类疾病风险人群的早期生物标志物。

相似文献

1
NDUFA12L mitochondrial complex-I assembly factor: Implications for taupathies.NDUFA12L线粒体复合物I组装因子:与tau蛋白病的关联
Appl Transl Genom. 2015 Jun 18;5:37-9. doi: 10.1016/j.atg.2015.05.003. eCollection 2015 Jun 1.
2
Tau aggregation into fibrillar polymers: taupathies.
FEBS Lett. 2000 Jun 30;476(1-2):89-92. doi: 10.1016/s0014-5793(00)01676-8.
3
Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias.神经退行性痴呆中tau蛋白病的临床病理评估与影像学表现
Alzheimers Res Ther. 2014 Jan 2;6(1):1. doi: 10.1186/alzrt231. eCollection 2014.
4
Dephosphorylation Targeting Chimaera (DEPTAC): Targeting Tau Proteins in Tauopathies.去磷酸化靶向嵌合体(DEPTAC):靶向神经纤维缠结病中的 Tau 蛋白。
Curr Protein Pept Sci. 2022;23(3):129-132. doi: 10.2174/1389203723666220519154229.
5
The unique neuroradiology of complex I deficiency due to NDUFA12L defect.
Mol Genet Metab. 2008 May;94(1):78-82. doi: 10.1016/j.ymgme.2007.11.013. Epub 2008 Jan 3.
6
Phosphorylation-Induced Structural Reorganization in Tau-Paired Helical Filaments.磷酸化诱导的双螺旋纤维中 tau 蛋白的结构重排。
ACS Chem Neurosci. 2021 May 5;12(9):1621-1631. doi: 10.1021/acschemneuro.1c00084. Epub 2021 Apr 20.
7
Modulation of tau protein aggregation using 'Trojan' sequences.利用“木马”序列调节 tau 蛋白聚集。
Biochim Biophys Acta Gen Subj. 2020 Jul;1864(7):129569. doi: 10.1016/j.bbagen.2020.129569. Epub 2020 Feb 27.
8
Mechanism of neurofibrillary degeneration and pharmacologic therapeutic approach.神经原纤维变性机制及药物治疗方法
J Neural Transm Suppl. 2000;59:213-22. doi: 10.1007/978-3-7091-6781-6_22.
9
Similarities and Differences in the Pattern of Tau Hyperphosphorylation in Physiological and Pathological Conditions: Impacts on the Elaboration of Therapies to Prevent Tau Pathology.生理和病理条件下Tau蛋白过度磷酸化模式的异同:对预防Tau蛋白病变治疗方法制定的影响
Front Neurol. 2021 Jan 7;11:607680. doi: 10.3389/fneur.2020.607680. eCollection 2020.
10
Super-resolution imaging unveils the self-replication of tau aggregates upon seeding.超分辨率成像揭示了 tau 聚集物在接种后的自我复制。
Cell Rep. 2023 Jul 25;42(7):112725. doi: 10.1016/j.celrep.2023.112725. Epub 2023 Jul 1.

引用本文的文献

1
Mitochondrial protein dysfunction in pathogenesis of neurological diseases.线粒体蛋白功能障碍在神经疾病发病机制中的作用
Front Mol Neurosci. 2022 Sep 7;15:974480. doi: 10.3389/fnmol.2022.974480. eCollection 2022.

本文引用的文献

1
Invited review: Neuropathology of tauopathies: principles and practice.特邀综述:tau蛋白病的神经病理学:原理与实践
Neuropathol Appl Neurobiol. 2015 Feb;41(1):3-23. doi: 10.1111/nan.12208.
2
Advances in therapeutics for neurodegenerative tauopathies: moving toward the specific targeting of the most toxic tau species.神经退行性tau蛋白病治疗方法的进展:迈向最具毒性tau蛋白亚型的特异性靶向治疗
ACS Chem Neurosci. 2014 Sep 17;5(9):752-69. doi: 10.1021/cn500143n. Epub 2014 Aug 8.
3
Shared mechanisms of neurodegeneration in Alzheimer's disease and Parkinson's disease.阿尔茨海默病和帕金森病中神经退行性变的共同机制。
Biomed Res Int. 2014;2014:648740. doi: 10.1155/2014/648740. Epub 2014 May 12.
4
Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo.携带神经原纤维缠结的神经元在体内的皮质回路中具有功能性整合。
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):510-4. doi: 10.1073/pnas.1318807111. Epub 2013 Dec 24.
5
Preferential selectivity of inhibitors with human tau protein kinase gsk3β elucidates their potential roles for off-target Alzheimer's therapy.抑制剂对人tau蛋白激酶gsk3β的优先选择性阐明了它们在非靶向阿尔茨海默病治疗中的潜在作用。
Int J Alzheimers Dis. 2013;2013:809386. doi: 10.1155/2013/809386. Epub 2013 Oct 10.
6
Tau pathology and neurodegeneration.tau 病理学与神经退行性变。
Lancet Neurol. 2013 Jun;12(6):609-22. doi: 10.1016/S1474-4422(13)70090-5.
7
Amyloid-β forms fibrils by nucleated conformational conversion of oligomers.淀粉样蛋白-β通过寡聚物的成核构象转化形成原纤维。
Nat Chem Biol. 2011 Jul 31;7(9):602-9. doi: 10.1038/nchembio.624.
8
Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice.tau 寡聚物损害野生型小鼠的记忆并诱导突触和线粒体功能障碍。
Mol Neurodegener. 2011 Jun 6;6:39. doi: 10.1186/1750-1326-6-39.
9
Human platelets tau: a potential peripheral marker for Alzheimer's disease.人血小板微管相关蛋白 tau:阿尔茨海默病潜在的外周标志物。
J Alzheimers Dis. 2011;25(1):103-9. doi: 10.3233/JAD-2011-101641.
10
Differential regional distribution of phosphorylated tau and synapse loss in the nucleus accumbens in tauopathy model mice.在tau 病模型小鼠的伏隔核中,磷酸化 tau 和突触丢失的差异区域性分布。
Neurobiol Dis. 2011 Jun;42(3):404-14. doi: 10.1016/j.nbd.2011.02.002. Epub 2011 Feb 13.